Nothing Special   »   [go: up one dir, main page]

Zhao et al., 2024 - Google Patents

The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications

Zhao et al., 2024

View HTML
Document ID
8134894861700317095
Author
Zhao H
Song J
Li X
Xia Z
Wang Q
Fu J
Miao Y
Wang D
Wang X
Publication year
Publication venue
Frontiers in Immunology

External Links

Snippet

Pulmonary hypertension (PH) is a malignant disease with progressive increase of pulmonary vascular pressure, which eventually leads to right heart failure. More and more evidences show that immune cells and inflammation play an important role in the …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]

Similar Documents

Publication Publication Date Title
Mai et al. Targeting IL-1β in the Treatment of Atherosclerosis
von Stebut et al. IL-17A in psoriasis and beyond: cardiovascular and metabolic implications
Zhu et al. Interleukins and ischemic stroke
Sommer et al. Intestinal mucosal wound healing and barrier integrity in IBD–crosstalk and trafficking of cellular players
Sziksz et al. Fibrosis related inflammatory mediators: role of the IL‐10 cytokine family
Proto et al. Regulatory T cells promote macrophage efferocytosis during inflammation resolution
Lawrance et al. Cellular and molecular mediators of intestinal fibrosis
Weber et al. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Woytschak et al. Type 2 interleukin-4 receptor signaling in neutrophils antagonizes their expansion and migration during infection and inflammation
Udalova et al. Macrophage heterogeneity in the context of rheumatoid arthritis
Gao et al. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice
Lo Re et al. CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions
Longman et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Jin et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators
Roller et al. Blockade of phosphatidylinositol 3-kinase (PI3K) δ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis
Ritvo et al. Interleukin-1 in the response of follicular helper and follicular regulatory T cells
Zhao et al. The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications
Bhalla et al. Airway eosinophilopoietic and autoimmune mechanisms of eosinophilia in severe asthma
Fisman et al. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof
Bonomo et al. AT cell view of the bone marrow
Chaudhari et al. Deficiency of HIF1α in antigen-presenting cells aggravates atherosclerosis and type 1 T-helper cell responses in mice
Rahman et al. Insights from pre-clinical and clinical studies on the role of innate inflammation in atherosclerosis regression
Yang et al. The roles of noncardiomyocytes in cardiac remodeling
Kuan et al. Treg cells in atherosclerosis
De Luca et al. Interleukin-1 and systemic sclerosis: getting to the heart of cardiac involvement